Minnesota-based UAS Laboratories, Inc., has become the sole owner of Wisconsin’s APN Labs after acquiring all the outstanding shares, enabling the company to offer a ‘complete range of probiotics’.
APN Labs, active in the US for the past ten years, operates a facility and equipment that meet the strict FDA and state health department requirements as well as the current Good Manufacturing Practice (cGMP) guidelines, said UAS Labs.
“With the acquisition of APN Labs, we are now in a great position to provide a complete range of probiotics and other specialty nutritional supplements including our branded products as well as customer private label products,” said Dr S.K. Dash, president of UAS Laboratories.
“UAS Labs has extensive experience in formulation of probiotics and other specialty nutraceuticals and we will now be able to offer many more services,” added Dr Dash.
APN Labs’s expertise in custom manufacturing and private labels currently allows the development of products from conception to completion for their customers, said UAS, with product options including bulk capsules, tablets and powder.
In an email with NutraIngredients-USA, Dr Dash confirmed that this is the first acquisition made by UAS Labs, and that the company "is looking forward to other acquisitions in near future".